Table 2 Models depicting the association of leukocyte telomere length (LTL) with age and mortality across diverse racial populations
Characteristics | White | Black | Hispanic | Asian | Combined |
---|---|---|---|---|---|
Regression models for Age* | |||||
Unadjusted LTL | Â | Â | Â | Â | Â |
PF Cohort | (n = 1613) | (n = 162) | (n = 187) | (n = 70) | (n = 2046) |
    All, R (Root MSE) | −0.21 (0.27) | −0.29 (0.24) | −0.39 (0.28) | −0.17 (0.29) | −0.30 (0.28) |
    95% CI | −0.26 to −0.17 | −0.43 to −0.14 | −0.51 to −0.26 | −0.40 to 0.07+ | −0.33 to −0.26 |
  HRS Cohort | (n = 4319) | (n = 779) | (n = 614) | (n = 96) | (n = 5808) |
    All, R (Root MSE) | −0.04 (0.65) | −0.02 (1.11) | −0.12 (0.59) | −0.07 (0.63) | −0.05 (0.73) |
    95% CI | −0.07 to −0.01 | −0.10 to −0.05 | −0.42 to −0.05 | −0.26 to −0.14 | −0.08 to −0.03 |
Standardized LTL** | |||||
PF cohort | (n = 1613) | (n = 162) | (n = 187) | (n = 70) | (n = 2046) |
    All, R (Root MSE) | −0.22 (1.08) | −0.33 (0.96) | −0.31 (1.07) | −0.14 (1.10) | −0.28 (1.08) |
    95% CI | −0.27 to −0.17 | −0.46 to −0.18 | −0.44 to −0.18 | −0.36 to 0.10+ | −0.32 to −0.24 |
HRS cohort | (n = 4319) | (n = 779) | (n = 614) | (n = 96) | (n = 5808) |
    All, R (Root MSE) | −0.13 (1.09) | −0.15 (1.10) | −0.29 (1.09) | −0.35 (1.09) | −0.17 (1.10) |
    95% CI | −0.16 to −0.10 | −0.22 to −0.09 | −0.36 to −0.21 | −0.51 to −0.16 | −0.19 to −0.14 |
PF mortality risk models | (n = 1613) | (n = 162) | (n = 187) | (n = 70) | (n = 2046) |
#Overall crude mortality rate | 8.92 | 5.27 | 9.62 | 6.62 | 8.49 |
    (95% CI) | (8.16–9.76) | (3.91–7.10) | (7.47–12.38) | (3.84–11.40) | (7.83–9.20) |
+Mortality incidence rate ratio, TL50 | 2.10 | 2.09 | 2.79 | 2.67 | 2.31 |
    (95% CI) | (1.71–2.59) | (1.07–4.07) | (1.66–4.69) | (0.89–8.03) | (1.93–2.78) |
*Mortality hazard ratio for TL50 | 2.21 | 2.22 | 3.40 | 2.11 | 2.47 |
    (95% CI) | (1.79–2.72) | (1.05–4.66) | (1.88–6.14) | (0.54–8.23) | (2.05–2.97) |